Pharma: Novartis shares drop nearly 10% following three drug trial setbacks, marking the company's worst day on record.
Novartis shares plummeted Tuesday following disappointing results from their del-desiran drug trial, leaving investors concerned. 📉💔 #Novartis #PharmaNews
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0